Advertisement
U.S. markets close in 1 hour 28 minutes

Day One Biopharmaceuticals, Inc. (DAWN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
15.16+0.15 (+1.00%)
As of 02:32PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close15.01
Open15.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range14.97 - 15.23
52 Week Range9.67 - 18.07
Volume311,763
Avg. Volume994,045
Market Cap1.49B
Beta (5Y Monthly)-1.52
PE Ratio (TTM)N/A
EPS (TTM)-1.94
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est39.38
  • Insider Monkey

    Day One Biopharmaceuticals (DAWN): Advancing Targeted Therapies for Pediatric Glioma

    We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a look at where Day One Biopharmaceuticals (NASDAQ:DAWN) stands against other biggest stocks with negative beta to consider. Beta is a measureament of market risk or volatility that indicates how much the price […]

  • GlobeNewswire

    Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024

    BRISBANE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Wednesday, October 30, 2024 at 4:30 p.m. ET to report financial results and discuss corporate progress for the third quarter 2024. Live audio of the webcast will b